NOVEL CELL-PERMEABLE SUCCINATE COMPOUNDS

The present invention provides novel cell-permeable succinates and cell permeable precursors of succinate aimed at increasing ATP-production in mitochondria. The main part of ATP produced and utilized in the eukaryotic cell originates from mitochondrial oxidative phosphorylation, a process to which...

Full description

Saved in:
Bibliographic Details
Main Authors Ehinger, Karl Henrik Johannes, Moss, Steven, Elmer, Eskil, Hansson, Magnus Joakim
Format Patent
LanguageEnglish
Published 30.12.2021
Subjects
ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Abstract The present invention provides novel cell-permeable succinates and cell permeable precursors of succinate aimed at increasing ATP-production in mitochondria. The main part of ATP produced and utilized in the eukaryotic cell originates from mitochondrial oxidative phosphorylation, a process to which high-energy electrons are provided by the Kreb's cycle. Not all Kreb's cycle intermediates are readily permeable to the cellular membrane, one of them being succinate. The provision of the novel cell permeable succinates is envisaged to allow passage over the cellular membrane and thus the cell permeable succinates can be used to enhance mitochondrial ATP-output.
AbstractList The present invention provides novel cell-permeable succinates and cell permeable precursors of succinate aimed at increasing ATP-production in mitochondria. The main part of ATP produced and utilized in the eukaryotic cell originates from mitochondrial oxidative phosphorylation, a process to which high-energy electrons are provided by the Kreb's cycle. Not all Kreb's cycle intermediates are readily permeable to the cellular membrane, one of them being succinate. The provision of the novel cell permeable succinates is envisaged to allow passage over the cellular membrane and thus the cell permeable succinates can be used to enhance mitochondrial ATP-output.
Author Hansson, Magnus Joakim
Moss, Steven
Ehinger, Karl Henrik Johannes
Elmer, Eskil
Author_xml – fullname: Ehinger, Karl Henrik Johannes
– fullname: Moss, Steven
– fullname: Elmer, Eskil
– fullname: Hansson, Magnus Joakim
BookMark eNrjYmDJy89L5WTQ8PMPc_VRcHb18dENcA3ydXV08nFVCA51dvb0cwxxVXD29w3wD_VzCeZhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfGhwUYGRoYmBobmlkaOhsbEqQIAjVMmzg
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US2021401792A1
GroupedDBID EVB
ID FETCH-epo_espacenet_US2021401792A13
IEDL.DBID EVB
IngestDate Fri Jul 19 13:03:17 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US2021401792A13
Notes Application Number: US202117474482
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20211230&DB=EPODOC&CC=US&NR=2021401792A1
ParticipantIDs epo_espacenet_US2021401792A1
PublicationCentury 2000
PublicationDate 20211230
PublicationDateYYYYMMDD 2021-12-30
PublicationDate_xml – month: 12
  year: 2021
  text: 20211230
  day: 30
PublicationDecade 2020
PublicationYear 2021
RelatedCompanies ABLIVA AB
RelatedCompanies_xml – name: ABLIVA AB
Score 3.3800073
Snippet The present invention provides novel cell-permeable succinates and cell permeable precursors of succinate aimed at increasing ATP-production in mitochondria....
SourceID epo
SourceType Open Access Repository
SubjectTerms ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title NOVEL CELL-PERMEABLE SUCCINATE COMPOUNDS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20211230&DB=EPODOC&locale=&CC=US&NR=2021401792A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp-LHlIJSfCl2XbumD0W2NGVKv1jXsbeRjAQEmcNV_PdNQqd72luSg8sHd7m7JL8LwKPjer7oSeFlA04VJCewWJ9SC3EUCOQLSm0FFE6zwbhy3-bevAUfWyyMzhP6o5MjSo1aSn2v9X69_j_EivTbys0ze5dNny_xNIzMJjqW0Yx0qc1oFJIij3JsYhxWpZlNNM1V0ucMZax0oBxplWmfzEYKl7LeNSrxKRwWkt-qPoMWX3XgGG__XuvAUdpcectio32bc3jK8hlJDEySxCrIJCXDUUKMssL4NRtOiYHztMirLCov4CEmUzy2ZJeLvxkuqnJ3fP1LaMvYn1-BQQc9YQvb4Tb3XdELKAqYg5CgAWPe0nOvobuP081-8i2cqKrOW2h3oV1_ffM7aWNrdq-X5hcFKXse
link.rule.ids 230,309,786,891,25594,76904
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFOebTsWPqQWl-FLsunZtH4Zsacam_WJtx95GMhIQZA5X8d_3Gjbd095CDi4f3OXyS_K7ADxatuPKNhov7wpWUXJ8g3cYMzzh-dJzJWNmRRSO4u6osF9nzqwGH1sujMoT-qOSI6JHLdDfS7Ver_4PsQL1tnL9zN-x6vNlmPcCfYOOEc3glloPBj2aJkFCdEJ6RabHEyWzK-uz-oiVDlwEhVWmfTodVLyU1W5QGZ7AYYr6luUp1MSyCQ2y_XutCUfR5sobixvvW5_BU5xMaagRGoZGSicR7Q9CqmUFIeO4n1ONJFGaFHGQncPDkOZkZGCT878Rzotst3-dC6gj9heXoLFuW5rStIQpXFu2feb53PI8yXzOnYVjX0Frn6br_eJ7aIzyKJyH4_jtBo4rkcphaLagXn59i1uMtyW_U9P0C-0ifgk
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=NOVEL+CELL-PERMEABLE+SUCCINATE+COMPOUNDS&rft.inventor=Ehinger%2C+Karl+Henrik+Johannes&rft.inventor=Moss%2C+Steven&rft.inventor=Elmer%2C+Eskil&rft.inventor=Hansson%2C+Magnus+Joakim&rft.date=2021-12-30&rft.externalDBID=A1&rft.externalDocID=US2021401792A1